Dr. Talaber joined the field of neuro-vision therapy after seeing a family member struggle with undiagnosed and untreated vision disorders following a concussion. Unfortunately this kind of situation is not uncommon, and over 50% of vision deficits are missed in traditional vision screenings. For those fortunate enough to be diagnosed, it can be very challenging to get objective information about the most helpful treatment options.
NVTI’s mission is to create awareness about the prevalence of vision disorders, and the most successful, scientifically validated treatments to resolve them. That’s why NVTI welcomes all new patients with a complimentary consultation with Dr. Talaber.
What to expect during a neuro-vision evaluation
Our thorough evaluations go beyond traditional eye exams by assessing visual skills necessary for daily activities, as well as determining how the brain processes visual information. Assessing these rarely examined visual skills is crucial to discovering the root cause of visual symptoms or performance deficiencies.
Each new patient receives a personalized Neuro-Vision Evaluation (NVE) that typically includes over 30 tests of visual performance across critical visual skills. A deficit in any of the visual skills tested can seriously impact quality of life, interfere with a student’s ability to learn, impair the ease of tasks at work, or hinder athletic performance.
After the Neuro-Vision Evaluation, results are analyzed alongside vision history, symptoms, and prior test results to discover a possible diagnosis. One week after your NVE, patients meet with Dr. Talaber to go over your results, individualized treatment program, and answer questions.
What happens in a neuro-vision treatment program
Treatment programs can vary depending on the diagnosis, but all of them rely heavily on resolving visual performance deficiencies through specialized techniques. The majority of these treatment protocols need to be guided by a vision therapy practitioner (whether in office or through telehealth) and supplemented with occasional at home techniques. The duration of these treatment programs is entirely dependent on the severity of symptoms and type of diagnosis, but typically range from 15 to 30 sessions.
Understanding the science behind neuro-vision therapy helps explain why repetition is so critical to a successful treatment program. Adults of all ages have been proven to have brains that are plastic (able to change) to train new abilities or restore lost ones. Our treatment process uses neuroplasticity to rewire and strengthen areas of the brain that process vision. As we repetitively train the eyes and brain to function at their full potential, it can permanently resolve the underlying issues impacting quality of life, interfere with learning or work, or hinder athletic performance.
Why our treatment programs are successful
NVTI provides customized, evidence-based vision therapy and rehabilitation programs. We achieve such successful patient outcomes by putting our patients at the center of their treatment. In addition to educating patients why each therapy technique helps them, we train patients on how to supplement their treatment with an at-home program. We also ensure our patients achieve the ideal conditions for successful treatment by giving guidance around lifestyle, nutrition, and supplementation.
Patient Success Story:
One of our patients began experiencing double vision, severe headaches, and light sensitivity after a concussion. He was unable to perform at his job because computer work was so uncomfortable and words on the screen were constantly doubled.
Based on his Neuro-Vision Evaluation, Dr. Talaber created a vision rehabilitation program designed to help the patient gradually return to work full-time. In addition to rehabilitation, his treatment included a lifestyle protocol to reduce light sensitivity and fatigue for computer work. With the support of supplementation and nutritional guidance, the patient’s recovery rapidly accelerated. After completing his vision rehabilitation program, his symptoms completely resolved, and he returned to work full time.
Dr. Talaber published this patient’s case as a poster presentation at an annual optometric conference in 2017.